LTB4 synthesis inhibitors (Naegis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameLTB4 synthesis inhibitors (Naegis)
Drug Alias Nameleukotriene synthesis inhibitors (Naegis)
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionLeukotriene B4 synthesis inhibitors
TargetsUpdating
Therapy Area/IndicationsInflammationPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNaegis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNaegis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsInflammationPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A